Rxo (RXO) Retained Earnings (2021 - 2025)
Historic Retained Earnings for Rxo (RXO) over the last 5 years, with Q4 2025 value amounting to -$384.0 million.
- Rxo's Retained Earnings fell 3521.13% to -$384.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$384.0 million, marking a year-over-year decrease of 3521.13%. This contributed to the annual value of -$384.0 million for FY2025, which is 3521.13% down from last year.
- Latest data reveals that Rxo reported Retained Earnings of -$384.0 million as of Q4 2025, which was down 3521.13% from -$338.0 million recorded in Q3 2025.
- In the past 5 years, Rxo's Retained Earnings ranged from a high of $6.0 million in Q4 2023 and a low of -$384.0 million during Q4 2025
- Its 5-year average for Retained Earnings is -$129.1 million, with a median of -$9.0 million in 2024.
- As far as peak fluctuations go, Rxo's Retained Earnings soared by 25000.0% in 2023, and later crashed by 637500.0% in 2024.
- Over the past 5 years, Rxo's Retained Earnings (Quarter) stood at -$2.0 million in 2021, then crashed by 100.0% to -$4.0 million in 2022, then soared by 250.0% to $6.0 million in 2023, then plummeted by 4833.33% to -$284.0 million in 2024, then tumbled by 35.21% to -$384.0 million in 2025.
- Its Retained Earnings stands at -$384.0 million for Q4 2025, versus -$338.0 million for Q3 2025 and -$324.0 million for Q2 2025.